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ABSTRACT In the yeast Saccharomyccs cerevwise, qiuta-
tions in either of two unlinked genes, RAM)-1or RAM2, abolish
the farnesyltrnsferae activity responsible for prenylation of
Ras proteins and the a-factor mating pheromone. Here we
report that thefunction ofRAM) antd RAM2 genme is required
for the membrane laliation ofRas proteins and a-factor. The
RAM2 gene was sequenced and can encode a 38-kDa protein.
We examined tie functional interaction ofRAM2 andRAMf by
expressing the genes in Escherchia colt. Extracts derived from
an E. coil strain that coexpressed RAM] and RAM2 efficiently
farnesylated a-factor peptide and Ras protein substrates. In
contrast, extracts derived from E. colN strains that expressed
either RAM gene alone were devoid of activity; however, when
the latter extracts were mixed, protein farnesyltransferaSe
activity was reconstituted. These results indicate that the yeast
farnesyl-protein transferase is comprised of Raml and Ram2
polypeptides. Although Raml is a component of the enzyme,
disruption of the RAM) gene in yeast was not lethal indicating
that the Raml-Ram2 farnesyltserase is not essential for
viability. In contrast, disruption ofRAM2 was lethal, suggest-
ing that Ram2 has an essential function in addition to its role
with Raml in protein farnesylation.
The post-translational modification of proteins by the cova-
lent attachment of isoprenoid groups plays an important role
in the membrane targeting of various proteins (1-5). Three
classes of prenylated proteins in eukaryotic cells have been
described. The first class, represented by certain fungal
mating pheromones, Ras proteins, and nuclear lamins, is
initially synthesized with a C-terminal CAAX sequence,
where X = Ser, Cys, Met, or Ala, and is modified by thioether
linkage of a C15 farnesyl group to the cysteine residue (6-9).
The second class of prenylated proteins, represented by the
y subunits of certain heterotrimeric G proteins and various
Ras-like proteins, is initially synthesized with different C-ter-
minal CAAX sequences, in which X = Leu or Phe, and is
modified by the attachment of a C20 geranylgeranyl group to
the cysteine residue (10-12). Members of both of these
classes of prenylated proteins are subsequently processed by
proteolytic removal of the three terminal amino acids and
methylation of the newly exposed carboxyl group of the
prenyl-cysteine (6, 10-15). The third class of prenylated
proteins, represented by the Yptl/Sec4 (Rab) family of
Ras-like GTPases that terminate with the sequence CC or
CXC, is also geranylgeranylated at a C-terminal cysteine
residue(s) (16-18).
The mammalian p21"5 protein farnesyltransferase is a
heterodimeric enzyme (19-21) that appears to be responsible
for the modification of all proteins that have the first type of
CAAX sequence noted above (22, 23). Geranylgeranyltrans-
ferase type I (GGTase I), which modifies proteins that
terminate with the second type of CAAX sequence (23-25),
is also a heterodimeric enzyme that appears to share a
common a subunit with the p21" protein farnesyltransferase
(21, 23). A third enzyme has been identified, GGTase II,
which geranylgeranylates the Yptl/Sec4 class of proteins
(21).
Genetic studies in yeast have identified three genes, each
of which uniquely affects one type of prenyltransferase
reaction. One of these genes, RAM) (also called DPRI), was
identified as a suppressor of RAs2ra19, a mutationally acti-
vated RAS allele (26, 27). This same gene was identified
based on its involvement in a-factor production (26, 28, 29)
and as a suppressor ofG protein function (30). ram) extracts
are defective in a-factor and Ras protein farnesyltransferase
activity but not in other prenyltransferase activities (21, 23,
31, 32). Furthermore, Raml protein produced in Escherichia
coli, although lacking enzyme activity on its own, biochem-
ically complements ram] extracts for a-factor peptide farne-
syltransferase activity (31). This result suggests that the
RAM] gene product is a necessary but insufficient compo-
nent of the protein farnesyltransferase. Mutants harboring
lesions in CDC43/CALI, a gene that shows homology to
RAM) (33), are specifically defective in GGTase I activity
(21, 23, 34). Another yeast gene that is homologous to RAM),
called BET2, affects the membrane localization of Yptl and
Sec4 proteins (35) and specifically affects yeast GGTase II
activity (21).
In this report we characterize another yeast gene, RAM2,
that was identified as an extragenic suppressor of RAS2val'9.
Previous reports have shown that ram2 mutants, like ram]
mutants, are defective in Ras protein farnesyltransferase
activity (23, 32). Here we report the DNA sequence ofRAM2
and present direct evidence that RAM] and RAM2 encode
the two essential subunits of yeast farnesyl-protein transfer-
ase.
MATERIALS AND METHODS
Yeast Strains and Materials. The ram2-1 mutants used in
this study were derived from the original mutant STS39 by
backcrosses to RS16-4C (26). Other yeast strains have been
described (26, 29, 36). Recombinant p21"5 was purified as
described (37). Biotinylated KTSCVIM peptide (38) was
obtained from Multiple Peptide Systems (San Diego). The
a-factor peptides YIIKGVFWDPAC and YIIKGVFWD-
PACVIA were synthesized by P. Shenbagamurthi (Johns
Abbreviations: CAAX, protein sequence where C = cysteine, A =
usually an aliphatic amino acid, and X = any amino acid; FPP,
farnesyl pyrophosphate; GGTase I, geranylgeranyltransferase type-
I; GGTase II, GGTase type II.
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Hopkins). [3H]Farnesyl pyrophosphate ([3H]FPP; 20 Ci/
mmol; 1 Ci = 37 GBq) was purchased from NEN.
Plasmid Constructions and Gene Disruptions. The integra-
tive mapping plasmid pBH43 contains the1l.85-kilobase-pair
(kbp) Sac I-Pst I RAM2 fragment inserted into pRS305 (39).
pram2::LEU2 was constructed by insertion ofthe 1.5-kbp Pst
I-Bgl II RAM2 fragment into pBH43 and gene replacements
were generated by digestion with Pst I and transformation
into the diploid strain TTSD1 (40). pram):: URA3 (pSM353)
contains the 4.6-kbp BamHI-Bgl II fragment of the RAM)
locus inserted into the vector pUC-4k, with the URA3
HindIII fragment in place of the RAM) HindIII fragment,
such that codons 1-322 are deleted (41). Gene replacements
were generated by digestion with EcoRI and transformation
into the diploid strain SM1060 (36). To express RAM2 in E.
coli, a RAM2 coding sequence cassette was generated by
PCR utilizing two oligonucleotide primers that overlapped
either the initiation codon or the termination codon shown in
Fig. 3. The relevant sequence ofthe 5' portion ofthe cassette
is CTCGAGGAAAAM, where the underlined ATG corre-
sponds to the initiation codon ofRAM2. The 3' portion ofthe
cassette contained an artificial BamHI site following the
termination codon. This cassette was inserted into the chlor-
amphenicol-resistance plasmid pBC-KS+ (Stratagene) that
had been cleaved withXho I and BamHI, to generate pBH57,
which utilizes the lac promoter to direct the synthesis of an
N-terminal lacZ-RAM2 fusion protein. To express RAM) in
E. coli, the plasmid pBH63 was constructed by inserting a Sal
I-Kpn I RAM] coding sequence cassette into the ampicillin-
resistance plasmid pUC119. The RAM) cassette was gener-
ated by PCR utilizing two oligonucleotide primers that over-
lapped either the initiation codon or the termination codon
reported for DPRI (41). The relevant sequence of the 5'
portion of the cassette is GTCGACTAIG, where the under-
lined ATG indicates the initiation codon of RAM].
Preparation of E. cofl Extracts for Farnesyltrnsferase As-
says. E. coli extracts were prepared by culturing JM110
double transformants to mid-logarithmic phase followed by
induction with 0.5 mM isopropyl fB-D-thiogalactoside and
incubation for 1 hr. Cells were collected, washed in extrac-
tion buffer (50 mM sodium Mes, pH 6.5/0.1 mM EGTA/0.1
mM MgC12/5% glycerol/2 mM phenylmethylsulfonyl fluo-
ride), transferred to 0.5-ml tubes, pelleted, and lysed in 200
,l of extraction buffer with glass beads and Vortex mixing.
Soluble fractions were prepared by centrifugation at 50,000 x
g for 1 hr.
Other Methods. Fractionation of yeast and detection of
a-factor and Ras2 proteins by immunoprecipitation were
performed as described (26, 36). Yeast. extracts were pre-
pared as described (32). Farnesyltransferase assays using
recombinant p21lS as substrate were performed and analyzed
as described (32). Assays using synthetic a-factor peptides
were carried out with 250 pmol of peptide essentially as
described (31).
EXPERIMENTAL RESULTS
Identification and Characterization of the ram2 Mutation.
Several yeast mutations suppress RAS2vall9, including ram),
cyr), and capl/srv2 (26, 27, 42, 43). Among the set of
RAS2v8119 extragenic suppressor mutants derived by heat-
shock selection from the MATa rasf RAS2va"l9 strain PT1-6
(26), some recessive mutations do not fall into these three
known complementation groups. One of these suppressors,
STS39, displayed two nonselected phenotypes: an inability to
grow well at high temperatures (370C) and a significant mating
defect. The mating defect was determined to be MATa-
specific and correlated with defective a-factor production.
Based on cosegregation of all three of these phenotypes
following a cross to a wild-type strain and subsequent anal-
ysis of 10 complete tetrads, these three phenotypes resulted
from a single mutation (ram2-1). ram2-1 has been previously
demonstrated to be unlinked to ram) (32).
ru2 Mutants Are Defettive in the Farnesylatlon and Mea.
brane Targeting of Both -Ras Proteins and the a-Factor Ma
Pheromone. It has been shown that extracts prepared from
ram2-1 mutants fail to farnesylate bacterially produced Ras
proteins in vitro (23, 32). We determined that ram2-) extracts,
like ram] extracts, are also defective in farnesylating a-factor
in vitro (data not shown). To determine whether the lack of
farnesylation measured in vitro was reflected in vivo by a
defect in membrane targeting, we radiolabeled wild-type and
mutant yeast cells and examined soluble and particulate
fractions by immunoprecipitation using antibodies that rec-
ognized Ras proteins or a-factor (Fig. 1). In the wild-type
strain, Ras2 was localized in the particulate fraction as an
apparent 40-kDa species. In contrast, in the ram2-1 and the
ram) mutants, Ras2 was localized to the soluble fraction and
migrated more slowly (Fig. lA). Fig. 1B shows that a-factor
was detected in the particulate fraction of wild-type cells as
two precursor species (P1 and P2), whereas a-factor synthe-
sized in ram) or ram2-1 mutants was predominantly localized
in the soluble fraction as a slower migrating form (PO). Thus,
ram2-1, like mutations in RAM), blocks the membrane
targeting of Ras proteins and a-factor.
Cloing and Sequence Analysis of RAM2. We utilized the
Ts- phenotype of ram2-1 mutants to clone the wild-type
RAM2 gene by complementation. A ram2-1 mutant strain
was transformed with a yeast genonuc library and two
transformants were found that exhibited plasmid-dependent
Ts' growth. Plasmids recovered from these two transform-
ants restored normal growth and mating properties to ram2
mutant strains. Restriction enzyme mapping revealed that the
two plasmids contained overlapping inserts with a common
region ofDNA of >11 kbp (Fig. 2). To determine whether the
gene we cloned corresponded to the locus identified by the
ram2-1 mutation, we integrated a LEU2 '-marked plasmid
(pBH43) containing a fragment of the cloned DNA into a
RAM2 + strain. Integration was targeted to the chromosomal
locus corresponding to the cloned fragment by digestion with
Sph I (see Fig. 2), and correctly targeted integration was
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FIG. 1. Localization ofRas proteins and a-factor in ram mutants.
(A) SDS/PAGE analysis of immunoprecipitated Ras2 proteins from
soluble (S) and particulate (P) fractions of extracts prepared from[35S]methionine-labeled wild-type and mutant yeast strains, all of
which contained high-copy RAS2 plasmid (26). Lanes: 1, wild-type
(SP1); 2, ram2-1 (STS39); 3, ram)-) (STS11). The soluble precursor
form of Ras2 (41 kDa) and the particulate mature form of Ras2 (40
kDa) are marked by arrows. (B) SDS/PAGE analysis of immuno-
precipitated a-factor from total extracts (T) and particulate (P) and
soluble (S) fractions of total extracts prepared from [35Slcysteine-
labeled wild-type and mutant yeast strains, all of which contained
high-copy MFal plasmid (29). Lanes: 1, wild-type (SM1229); 2,
ram)::URA3 (SM1866); 3, ram2-) (SM1863). Three of the intracel-
lular forms of a-factor are marked by arrows (PO, P1, P2).
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FIG. 2. Restriction map of the RAM2 locus and the ram2::LEU2
gene disruption construct. The restriction map of the RAM2 locus is
shown. Both of the original library plasmid isolates contained
additional regions ofDNA (-6 kbp) that are not shown in this map.
Shown above the map is the -y-disruption vector pram2::LEU2,
which contains two noncontiguous fragments from the RAM2 region
inserted in a head-to-tail orientation into the yeast integration vector
pRS305 (39). Integration of the plasmid into the RAM2 locus results
in the deletion of the RAM2 coding region that resides between the
indicated Bgl II and Sac I restriction sites.
confirmed by DNA-blot hybridization for the transformant
BHYDC1. In a cross of a ram2-1 ieu2 strain with BHYDC1,
the segregation pattern of LEU2+ and ram2-1 indicated
complete linkage (no recombinants in 25 tetrads), and we
therefore conclude that the cloned gene is indeed RAM2.
Subclones of the two original plasmids were constructed
and based on their ability to complement the ram2 mutation
we determined that the entire RAM2 gene (or at least a
functional segment) resided within the 1.4-kbp Xba I-Sph I
fragment shown in Fig. 2. The DNA sequence of this region
was determined for both strands and it contains an open
reading frame that can encode a protein of 316 amino acids if
the first ATG is used to initiate translation (Fig. 3). The
predicted molecular mass of the Ram2 protein is 38 kDa.
Reconstitution of Farnesyltransferase Activity. To investi-
gate the possibility that Raml and Ram2 proteins are indeed
structural subunits of the yeast farnesyl-protein transferase,
we expressed the RAM] and RAM2 genes in E. coli and
assayed extracts for farnesyltransferase activity. Using a
substrate peptide corresponding to the C-terminal sequence
of K-rasB, control extracts and extracts prepared from
bacterial strains that expressed either RAM] or RAM2 gene
alone were completely inactive (Table 1). In contrast, ex-
tracts prepared from a strain that coexpressed RAM) and
RAM2 exhibited high levels of famesyltransferase activity
(Table 1). We have determined that the specific activity of
such E. coli extracts is at least 100-fold higher than that of
similarly prepared wild-type yeast extracts (data not shown).
Extracts prepared from E. coli cells that coexpressed
RAM) and RAM2 also efficiently farnesylated synthetic
a-factor substrate. We observed by SDS/PAGE analysis that
control extracts derived from E. coli carrying plasmids with-
out RAM inserts produced an unidentified product from
[3H]FPP (Fig. 4A, lane 3) that is not related to a-factor since
it was also observed in reactions in which the peptide was
absent (Fig. 4A, lane 9). In contrast, using extracts from cells
that coexpressed RAM] and RAM2, a reaction product was
observed (Fig. 4A, lane 1) that was not found in reactions
utilizing extracts prepared from E. coli that expressed either
the RAM) orRAM2 gene alone (Fig. 4A, lanes 4 and 5). This
product comigrated with authentic mature a-factor produced
in vivo (Fig. 4B) and was not detected in control reactions
containing a synthetic a-factor peptide from which the ter-
minal-AAX residues (of the CAAX sequence) were missing
(Fig. 4A, lane 8).
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FIG. 3. Nucleotide sequence of the RAM2 region and predicted
amino acid sequence of the Ram2 protein.
We tested whether farnesyltransferase activity could be
reconstituted by mixing E. coli extracts containing Raml
alone with extracts containing Ram2 alone. The results
shown in Table 1 indicate that these extracts, when mixed, do
indeed exhibit farnesyltransferase activity. The activity pro-
duced by the mixed extract was -25-fold lower than that
observed with E. coli extracts from cells that coexpressed
Table 1. Farnesyltransferase activity in extracts from E. coli
RAM gene expressed [3H]FarnesylE. coli transferred,
transformant RAM] RAM2 pmol per tube
BHE-1
- - <0.006
BHE-2 + - <0.004
BHE-3
- + <0.002
BHE-4 + + 5.5 ± 0.1
Mixed extract + + 0.19 ± 0.02
The E. coli host JM110 was transformed sequentially with two
different plasmids to generate the strains used in this experiment.
Each assay (25 jl) was performed in duplicate and contained 50 mM
potassium phosphate (pH 7.4), 10 mM MgCl2, 5 mM dithiothreitol,
0.2% Tween 20, 50 ,ug of soluble extract from the indicated E. coil
transformant, 90 pmol of biotinylated KTSCVIM peptide, and 25
pmol of [3H]FPP. After incubation for 30 min at 300C, the amount of
[3H]farnesyl transferred to peptide was measured as described (38).
For the mixed extract, 50 zg of BHE-2 and BHE-3 E. coli extracts
was mixed in a microcentrifuge tube and left on ice for 30 min before
performing the assay. In a separate experiment, BHE-4 extract
transferred 1.6 ± 0.1 pmol of [3H]farnesyl onto bacterially produced
p211, whereas control extracts listed transferred <6 fmol to Ras
substrate.
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FIG. 4. SDS/PAGE analysis of a-factor famesyltransferase ac-
tivity in E. coli extracts. (A) Farnesylation assays with the a-factor
quindecapeptide substrate were performed (see text) and analyzed
by SDS/PAGE and fluorography. Unless otherwise stated, all reac-
tion mixtures contained buffer, [3H]FPP, the a-factor 15-mer sub-
strate, and an E. coli extract. Mock reactions are shown in which the
E. coli extract and peptide substrate (lane 1) or E. coli extract only
(lane 2) is absent. Lanes 3-7 display complete reactions containing
extract from the control E. coli strain BHE-1 (lane 3), extract from
BHE-2, which expresses RAM] alone (lane 4), extract from BHE-3,
which expresses RAM2 alone (lane 5), a mixture of extracts from
BHE-2 and BHE-3 (lane 6), and extract from BHE-4, which coex-
presses RAM] and RAM2 (lane 7). Lanes 8 and 9 represent control
reactions identical to that shown in lane 7 but with substitution with
the 12-mer a-factor substrate (lane 8) or no peptide substrate (lane 9).
(B) Comigration of in vitro farnesylated a-factor and authentic
a-factor. Lane 1, same reaction mixture as in lane 7 of A. Lane 2,
a-factor that was immunoprecipitated from the culture supernatant of
a MATa strain that had been radiolabeled with [35S]cysteine (36, 44).
RAM) and RAM2 genes (Table 1). The lower activity of
mixed extracts was also observed in experiments utilizing
Ras proteins as substrate (data not shown) and in reactions
utilizing the quindecapeptide a-factor as substrate (Fig. 4A,
lane 6).
Effect of Disruption ofRAM) andRAM2 Genes in Yeast. To
examine whether the Raml-Ram2 farnesyl-protein transfer-
ase was essential for yeast viability, we made plasmids that
contained deletion alleles of RAM) and RAM2. By DNA
transformation, we constructed diploids that were heterozy-
gous for one ofthe disruptedRAM alleles. Analysis oftetrads
from a ram2/RAM2+ diploid indicated that ram2 null mu-
tants were nonviable; 2:2 segregation of viability was ob-
served in 30 tetrads, and all 60 viable colonies were Leu-,
indicating that they contained a wild-type RAM2 gene. By
microscopic examination, we observed that ram2- spores
occasionally germinated and divided up to four times but then
ceased growing.
To test for the effects of disrupting the RAM) gene, we
analyzed tetrads derived from a ram) -/RAM) + diploid. We
observed that at 300C ram) spores germinated and slowly
formed colonies, indicating that ram) null mutants are viable
(Fig. 5). Further analysis indicated that ram) null mutants
were significantly defective for growth at low temperatures
and completely unable to grow at 37TC (Fig. 5).
The viability of ram) null mutants is in marked contrast to
the lethal effects of disrupting the RAM2 gene. This is not due
to genetic variations in the strains employed since disruption
ofRAM] was not lethal in the strains used to test the effects
of RAM2 disruption (data not shown). To explore the pos-
sibility of residual protein farnesyltransferase activity in
ram) null mutants, we prepared soluble extract from a ram)
null mutant and assayed for farnesyltransferase activity. No
reaction product was observed using the a-factor quinde-
capeptide substrate, even after long exposures of the fluo-
rogram (data not shown). The amount of [3H]farnesyl trans-
ferred to the K-rasB peptide using the ram] null mutant
extract was not significantly higher than blank values (<2
fmol), whereas parallel reactions with extract prepared from
the wild-type strain SP1 transferred 284 + 50 fmol. Since we
did not detect residual protein farnesyltransferase activity in
ram] null mutants, we conclude that this activity is not
required for yeast viability. This raises a paradox, since RAS
function is essential in yeast. Possible resolution of the
paradox, and explanations for the disparate effects of dis-
rupting RAM) and RAM2, are discussed below.
DISCUSSION
We have characterized a newly identified yeast gene, RAM2,
and have shown by expression in E. coli that RAM) and
RAM2 encode the two required components of the yeast
enzyme responsible for farnesylation of a-factor and Ras
proteins. The finding that Raml and Ram2 proteins are
required for reconstitution of protein farnesyltransferase
activity parallels the finding that the mammalian Ras protein
farnesyltransferase is comprised oftwo different polypeptide
subunits (19-21). It is also noteworthy that both components
of the mammalian enzyme, the f3 subunit and the a subunit,
are structurally homologous to Raml and Ram2, respectively
(21, 45, 46).
RAS function is essential for yeast, and mutant Ras pro-
teins that cannot be farnesylated cannot supply essentialRAS
function unless significantly overexpressed (47-49). It is
therefore somewhat surprising that RAM), which is abso-
lutely required for farnesyl-protein transferase activity, is not
an essential gene. One possible explanation, based on the
ability of CAAX peptides that are efficient substrates for the
farnesyl-protein transferase to serve as less efficient sub-
strates for GGTase I, is that in ram) - mutant cells a small but
sufficient amount of Ras proteins is geranylgeranylated by
yeast GGTase I (22, 23, 25). Accordingly, we propose that
FIG. 5. Tetrad analysis of raml-/RAM)Idiploids and the growth phenotype of the segregants. (A) Tetrads after sporulation and dissection
of the diploid SM1589 (ram:: URA3/RAMI), derived from SM1060 (36), were grown on YEPD plates for 6 days at 30'C. Nine of 10 tetrads
displayed 2:2 segregation of slow growth. All slow-growing colonies were determined to be Ura', indicating that they contained the ram)::URA3
allele. (B) All four colonies from a single tetrad were streaked onto a YEPD plate and incubated at 300C for 3 days. The two ramP::URA3
segregants grew much slower than the two wild-type segregants. (C) All four colonies from a single tetrad were streaked onto a YEPD plate
and incubated at 370C for 3 days. The two ramP:: URA3 segregants did not grow at all.
11376 Biochemistry: He et al.
a z-., --ii---a-factor
Proc. Natl. Acad. Sci. USA 88 (1991) 11377
ram2- null mutants are nonviable as a result of not only
deficient farnesyltransferase activity but also deficient
GGTase I activity. This proposal is based in part on the
finding that the mammalian a subunit of the farnesyl-protein
transferase, which is homologous to Ram2, also appears to be
a structural subunit ofGGTase I (21, 24). In addition, ram2-1
mutants have been shown to be somewhat defective in
GGTase I activity (23). Further analysis will be required to
fully understand the role of Ram2 in other prenyltransferase
reactions.
Two of the three yeast enzymes postulated to be involved
in the post-translational modification of Ras proteins and
a-factor have now been definitively assigned to particular
genes in Saccharomyces cerevisiae and have been reconsti-
tuted by expression in E. coli. In addition to the Raml-Ram2
farnesyl-protein transferase, it has been shown that STEJ4
encodes the methyltransferase that modifies a-factor and Ras
proteins (36). In the absence of STEJ4 function, prior steps
in Ras protein processing, presumably prenylation or prote-
olytic removal of the three C-terminal amino acids, were
significantly delayed. This finding suggests that different
steps in the modification of Ras proteins, although biochem-
ically separable, may somehow be coupled in vivo.
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